REZOLUTE, INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
REZOLUTE, INC. (RZLT) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $10.70 million as of 2024-12-31, per its 10-Q filed 2025-02-12.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2025-02-12
- 2024-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $10.70M.
- 2024-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $10.40M.
- 2024-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $11.60M.
- 2024-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $13.00M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2024-12-31 | $10.70M 10-Q · filed 2025-02-12 |
| 2024-09-30 | $10.40M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $11.60M 10-K · filed 2024-09-19 |
| 2024-03-31 | $13.00M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $13.50M 10-Q · filed 2024-02-13 |
| 2023-09-30 | $15.40M 10-Q · filed 2023-11-13 |
| 2023-03-31 | $18.80M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $20.20M 10-Q · filed 2023-02-10 |
| 2022-09-30 | $22.20M 10-Q · filed 2022-11-09 |
| 2021-03-31 | $1.50M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $2.20M 10-Q · filed 2021-02-10 |
| 2020-09-30 | $2.60M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $3.40M 10-K · filed 2020-10-13 |
| 2020-03-31 | $4.00M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $4.80M 10-Q · filed 2020-02-12 |
| 2019-09-30 | $5.30M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $2.70M 10-K · filed 2019-09-10 |
| 2019-03-31 | $3.04M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $3.05M 10-Q · filed 2019-02-14 |
| 2018-03-31 | $7.14M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $8.64M 10-Q · filed 2018-02-14 |
| 2017-09-30 | $10.27M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $12.89M 10-K · filed 2017-09-22 |
| 2017-03-31 | $12.92M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $14.13M 10-Q · filed 2017-02-02 |
| 2016-09-30 | $7.09M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $7.90M 10-K · filed 2016-09-28 |
| 2016-03-31 | $8.60M 10-Q · filed 2016-05-16 |
| 2015-12-31 | $9.51M 10-Q · filed 2016-02-16 |
| 2015-09-30 | $10.50M 10-Q · filed 2015-11-16 |
| 2015-06-30 | $11.47M 10-K · filed 2015-09-28 |
| 2015-03-31 | $12.40M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $6.54M 10-Q · filed 2015-02-17 |
| 2014-09-30 | $7.05M 10-Q · filed 2014-11-12 |
| 2014-06-30 | $7.76M 10-K · filed 2014-09-30 |
| 2014-03-31 | $6.89M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $1.35M 10-Q · filed 2014-02-13 |
| 2013-09-30 | $1.52M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $1.68M 10-K · filed 2013-09-11 |
| 2013-03-31 | $2.07M 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |